In a BPC-157 and TB-500 stack, it is common to keep the BPC-157 dose at the standard 250-500 mcg range, as its action is highly localized, but reduce the TB-500 dose to the lower end of the range (e.g., 2.5 mg per week) for systemic support
It is not FDA-approved, is not a weight-loss medication, and any use should be discussed with a qualified prescriber
"Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials"
The answer has almost nothing to do with science and almost everything to do with the bureaucratic weirdness of compounding laws
Want to book a consultation or ask us a question
Patient safety and effective medical care hinge significantly on following established medical protocols and guidelines